dactinomycin has been researched along with busulfan in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (70.27) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (5.41) | 29.6817 |
2010's | 7 (18.92) | 24.3611 |
2020's | 2 (5.41) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bocaccino, CA; Greenberger, JS; Moloney, WC; Szot, SJ | 1 |
Opitz, U; Seidel, HJ | 2 |
Stukov, AN | 1 |
Blau, HJ | 1 |
Hardt, F | 1 |
Murphy, GP | 1 |
Almeyda, J; Levantine, A | 1 |
Lemmel, EM; Nouza, K | 1 |
Lemmel, EM; Motycka, K; Nouza, K; Soucek, J | 1 |
Sugiura, K | 1 |
Cappuccino, JG; Schmid, FA; Stock, CC; Tarnowski, GS | 1 |
Bradner, WT; Pindell, MH | 1 |
Armstrong, JG | 1 |
Blackett, NM; Constable, TB | 1 |
Barrio Rendo, ME; Buys, MC; Scaro, JL; Zenteno, A | 1 |
Carlisle, HN; Saslaw, S | 1 |
Jelínek, V; Rezábek, K | 1 |
Lohrmann, HP; Schreml, W | 1 |
Grönroos, M; Kauppila, A; Kauppila, O; Nieminen, U; Saksela, E; Väyrynen, M | 1 |
Blackett, NM; Twentyman, PR | 1 |
BIERMAN, HR | 1 |
GOLDENBERG, DM | 1 |
SULLI, G | 1 |
BEATTY, EC; BRUBAKER, C; HAMMOND, D; HARTMANN, JR; ORIGENES, ML; SHORE, N; WILLIAMS, KO | 1 |
CSANYI, E; HORVATH, P; INSTITORIS, L | 1 |
Bölling, T; Dirksen, U; Ernst, I; Jürgens, H; Ranft, A; Willich, N | 1 |
Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
Boddy, AV; Chatelut, E; Osborne, C; Paci, A; Veal, GJ; White-Koning, M | 1 |
Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
4 review(s) available for dactinomycin and busulfan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Eruptions; Erythema; Fluorouracil; Gynecomastia; Humans; Hydroxyurea; Methotrexate; Photosensitivity Disorders; Pigmentation Disorders; Radiation Injuries; Stomatitis; Vinblastine | 1974 |
Cytotoxic drugs and the granulopoietic system.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bone Marrow; Busulfan; Chlorambucil; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Cytotoxins; Dactinomycin; Fluorouracil; Granulocytes; Hematopoietic Stem Cells; Hematopoietic System; Humans; Methotrexate; Nitrogen Mustard Compounds; Nitrosourea Compounds; Vinblastine | 1982 |
[MEDICAL THERAPY OF MALIGNANT NEOPLASMS].
Topics: Antimetabolites; Antineoplastic Agents; Antiviral Agents; Blood Transfusion; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Diet; Diet Therapy; Estrogens; Female; Iodine Isotopes; Mechlorethamine; Methotrexate; Neoplasms; Phosphorus Isotopes; Prednisone; Pregnancy; Pregnancy Complications; Progesterone; Testosterone; Triethylenemelamine; Vinblastine; Vitamins | 1964 |
4 trial(s) available for dactinomycin and busulfan
Article | Year |
---|---|
A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.
Topics: Abdomen; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Finland; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Pelvis; Prospective Studies; Random Allocation; Vincristine | 1984 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
29 other study(ies) available for dactinomycin and busulfan
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Chemotherapeutic remissions in Wistar Furth rat acute myelogenous leukemia: a model for human AML.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Dexamethasone; Disease Models, Animal; Doxorubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Methotrexate; Rats; Remission, Spontaneous; Vinblastine; Vincristine | 1977 |
Effect of actinomycin D and busulphan on stem cells in normal and Friend virus infected mice.
Topics: Animals; Bone Marrow; Busulfan; Dactinomycin; Erythropoiesis; Female; Friend murine leukemia virus; Hematopoietic Stem Cells; Mice; Spleen; Time Factors | 1979 |
Studies on the target cell for the Friend virus (FV-P strain) using the CFU-E technique.
Topics: Animals; Busulfan; Cell Count; Cell Line; Colony-Forming Units Assay; Dactinomycin; Erythropoiesis; Female; Friend murine leukemia virus; Leukemia, Experimental; Mice; Polycythemia | 1978 |
[Combination chemotherapy of tumors (an experimental study)].
Topics: Animals; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Drug Therapy, Combination; Mice; Neoplasms, Experimental; Streptonigrin; Thiotepa; Time Factors; Vinblastine | 1975 |
[Side effects of cytostatic therapy in childhood].
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Fluorouracil; Humans; Male; Mannitol; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Time Factors; Triaziquone; Vinblastine; Vincristine | 1976 |
Acceleration of casein induced amyloidosis in mice by immunosuppressive agents.
Topics: Amyloid; Amyloidosis; Animals; Azathioprine; Busulfan; Caseins; Chloramphenicol; Cortisone; Dactinomycin; Daunorubicin; DNA; Female; Fluorouracil; Immunosuppressive Agents; Liver; Male; Mercaptopurine; Methotrexate; Mice; RNA; Spleen; Vinblastine | 1971 |
Proceedings: Cancer of the prostate.
Topics: Amides; Antineoplastic Agents; Arginase; Bleomycin; Busulfan; Carbamates; Chromomycins; Cyclic P-Oxides; Cyclohexanes; Cyclophosphamide; Dactinomycin; Dimethylamines; Drug Evaluation, Preclinical; Estranes; Ethylamines; Fluorouracil; Humans; Imidazoles; Male; Mitomycins; Nitrogen Mustard Compounds; Nitrosourea Compounds; Organophosphorus Compounds; Oxidoreductases; Plicamycin; Procarbazine; Prostate; Prostatic Neoplasms; Streptozocin; Triazines; Uracil Mustard; Vincristine | 1973 |
Runt diseases as a model of immunosuppressive therapy.
Topics: Aminopterin; Animals; Busulfan; Cyclophosphamide; Dactinomycin; Graft vs Host Disease; Immunosuppressive Agents; Mercaptopurine; Mice; Models, Theoretical; Spleen; Transplantation Immunology | 1966 |
[The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice].
Topics: Age Factors; Aminopterin; Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Tolerance; Graft vs Host Disease; Immunosuppressive Agents; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Skin Transplantation; Thioguanine; Transplantation, Homologous | 1967 |
Chemotherapy of induced skin tumors in mice.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Benz(a)Anthracenes; Busulfan; Carcinoma, Squamous Cell; Chlorambucil; Cortisone; Cyclophosphamide; Dactinomycin; Estradiol; Female; Fluorouracil; Hydroxyurea; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitroso Compounds; Papilloma; Skin Neoplasms; Testosterone; Triethylenemelamine | 1968 |
Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Topics: Animals; Antineoplastic Agents; Arsenicals; Busulfan; Cyclophosphamide; Dactinomycin; Diethylstilbestrol; Floxuridine; Fluorouracil; Hydrocortisone; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Urethane; Vinblastine | 1966 |
Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Busulfan; Cyclophosphamide; Dactinomycin; Female; Floxuridine; Fluorouracil; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Neoplasms, Experimental; Prednisone; Pyrazoles; Pyrimidines; Triethylenemelamine; Vinblastine; Vincristine | 1966 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Hydrazines; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mesenchymoma; Methotrexate; Multiple Myeloma; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pregnancy; Prostatic Neoplasms; Steroids; Testicular Neoplasms; Urethane; Vinblastine; Vincristine; Wilms Tumor | 1968 |
Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ability of rat bone marrow.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Clone Cells; Cyclophosphamide; Dactinomycin; Erythropoiesis; Female; In Vitro Techniques; Male; Methotrexate; Rats; Spleen; Thymidine; Transplantation, Homologous; Tritium | 1972 |
Proceedings: Studies on hemopoietic stem cell kinetics after a single high dose of actinomycin D (AM), cyclophosphamide (CY) and busulphan (BS) in the mouse.
Topics: Animals; Busulfan; Cell Differentiation; Cyclophosphamide; Dactinomycin; Hematopoiesis; Hematopoietic Stem Cells; Injections, Intraperitoneal; Kinetics; Mice; Organ Size; Radiation Effects; Spleen | 1973 |
Nonhuman primates in evaluation of hematotoxicity.
Topics: Animals; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug-Related Side Effects and Adverse Reactions; Folic Acid Antagonists; Haplorhini; Hematologic Diseases; Hematopoiesis; Infections; Leukocyte Count; Leukopenia; Mechlorethamine; Mercaptopurine; Models, Biological; Pyrimidines; Thiotepa; Triethylenemelamine; Vinblastine; Vincristine | 1969 |
Effect of cytostatics on the uterotrophic action of estrogens.
Topics: Aminopterin; Animals; Antineoplastic Agents; Benzoates; Busulfan; Castration; Colchicine; Cyclophosphamide; Dactinomycin; Estradiol; Female; Mercaptopurine; Pyrimidines; Rats; Uracil; Uterus | 1969 |
Action of cytotoxic agents on the erythroid system of the mouse.
Topics: Animals; Antineoplastic Agents; Busulfan; Cell Division; Dactinomycin; Dose-Response Relationship, Drug; Erythrocytes; Gamma Rays; Methotrexate; Mice; Mice, Inbred C57BL; Nucleic Acid Synthesis Inhibitors; Vinblastine | 1970 |
The chemotherapy of intrathoracic tumors.
Topics: Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Humans; Mechlorethamine; Methotrexate; Neoplasms; Prednisone; Progesterone; Testosterone; Thiotepa; Thoracic Neoplasms; Vinblastine | 1962 |
DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Busulfan; Colchicine; Dactinomycin; Diethylstilbestrol; Estrogens; Fluorouracil; Gonadal Steroid Hormones; Mercaptopurine; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Podophyllum; Progestins; Quinones; Thiotepa; Triethylenemelamine; Urethane; Vinblastine | 1963 |
TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.
Topics: Antineoplastic Agents; Busulfan; Child; Cyclophosphamide; Dactinomycin; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mercaptopurine; Neoplasms; Neuroblastoma; Sarcoma; Urea | 1964 |
[ON THE EFFECT OF GLUCOSE ON THE TOXIC AND THERAPEUTIC EFFECTS OF 1,6-DIBROMO-1,6-D-DIDESOXYMANNITOL IN ANIMAL EXPERIMENTS].
Topics: Aminopterin; Animal Experimentation; Animals; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Dactinomycin; Glucose; Mannitol; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 37; Sarcoma, Yoshida; Toxicology | 1964 |
Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cross-Sectional Studies; Dactinomycin; Dose-Response Relationship, Drug; Germany; Humans; Ifosfamide; Intestines; Lung; Melphalan; Multicenter Studies as Topic; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Registries; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Spinal Cord; Survivors; Vincristine | 2009 |
Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Area Under Curve; Busulfan; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Drug Dosage Calculations; Drug Monitoring; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Patient Safety; Risk Factors | 2018 |